Compare

Compare stocks side by side

Pick up to 3 companies to see where each one is stronger or weaker.

ATOSARGX

Atossa Therapeutics, Inc.

Area by area

Overall Quant Score

How does it look overall? (out of 100)

ATOS

56/100

ARGX

80/100

Quality

Is it a profitable, well-run business?

ATOS

2.0/10

ARGX

8.2/10

Growth

Is the company growing?

ATOS

0.0/10

ARGX

10.0/10

Valuation

Is the price reasonable? (higher = cheaper)

ATOS

7.5/10

ARGX

4.1/10

Risk

How risky are the shares? (higher = lower risk)

ATOS

3.4/10

ARGX

7.7/10

Momentum

Is the share price trending up?

ATOS

7.7/10

ARGX

7.5/10

Financial strength

Is the balance sheet healthy?

ATOS

5.0/10

ARGX

9.0/10

The balanced view

Model-generated

Atossa Therapeutics, Inc.

This company has a mixed profile, with supportive analyst views and a positive price trend, although its growth has been slow.

Leads on: valuation, momentum

Best feature: analysts broadly positive (Target upside: 1534.6%)

Watch out: growth is slow or negative (Net income growth (FY): -36.3%)

argenx SE

This company scores well across most areas, with solid growth and supportive analyst views, although its current valuation deserves attention.

Leads on: quality, growth, risk, financial strength

Best feature: solid growth (Revenue growth (FY): 89.6%)

Watch out: valuation may be demanding (DCF upside: -668.4%)

Different strengths suit different goals — a higher score in one area doesn’t make a stock the better choice for everyone.